Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Amplification and expression of a decoy receptor for fas ligand (DcR3) in virus (EBV or HTLV-I) associated lymphomas.

Cancer letters - 10 Nov 2000

Ohshima K, Haraoka S, Sugihara M, Suzumiya J, Kawasaki C, Kanda M, Kikuchi M

Abstract excerpt

The recently identified decoy receptor 3 (DcR3) binds to FasL and inhibits FasL-induced apoptosis, and is considered to play a role in the immune escape system of neoplastic cells. To examine the involvement of DcR3 in the immune evasions of virus-associated lymphoma, we analyzed the amplification and expression of DcR3, using dot blot and in situ hybridization (ISH), in 45 cases, which included 17 cases with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Burkitt Lymphoma
Share to Fas Ligand Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Amplification

Share to Herpesvirus 4, Human

Share to Hodgkin Disease

Share to Leukemia-Lymphoma, Adult T-Cell

Share to Receptors, Tumor Necrosis Factor

Share to RNA, Neoplasm

Source

Identifiers

PMID: 11098089
DOI: 10.1016/s0304-3835(00)00567-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Amplification and expression of a decoy receptor for fas ligand (DcR3) in virus (EBV or HTLV-I) associated lymphomas.PMID 11098089Read ↗

The prognostic significance of overexpression of the decoy receptor for Fas ligand (DcR3) in patients with gastric carcinomas.Semantic proximity Read ↗

Fas Ligand Expression in Hodgkin LymphomaSemantic proximity Read ↗

Autoimmune lymphoproliferative syndrome mimicking chronic active Epstein-Barr virus infection.Semantic proximity Read ↗

Ligand-independent signaling by overexpressed CD30 drives NF-kappaB activation in Hodgkin-Reed-Sternberg cells.Semantic proximity Read ↗

DcR3 gene polymorphisms are associated with sporadic breast infiltrating ductal carcinoma in Northeast Chinese women.Semantic proximity Read ↗

Dysregulation of CD95/CD95 ligand-apoptotic pathway in CD3(+) large granular lymphocyte leukemia.Semantic proximity Read ↗

Crystal Structure of the Complex of Human FasL and Its Decoy Receptor DcR3.Semantic proximity Read ↗

Polymorphisms of decoy receptor 3 are associated with risk of esophageal squamous cell carcinoma in Chinese Han.Semantic proximity Read ↗

Soluble Interleukin-13Rα2 Decoy Receptor Inhibits Hodgkin’s Lymphoma Growthin Vitroandin VivoSemantic proximity Read ↗

Expression of TNF-related apoptosis-inducing ligand (TRAIL) and its receptors in gastric carcinoma and tumor-infiltrating lymphocytes: a possible mechanism of immune evasion of the tumor.Semantic proximity Read ↗

The glycosaminoglycan-binding domain of decoy receptor 3 is essential for induction of monocyte adhesion.Semantic proximity Read ↗

Molecular characterization of a CD95 signaling mutant.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.